USPTO serial 90026492
VIVA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SETTLES LEWIS, SHAILA E
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VIVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Viva Biotech (Shanghai) Limited
Pudong Area, Shanghai, CN
Viva Biotech (Shanghai) Limited
Pudong Area, Shanghai, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard N. Aronson
Howard N. Aronson Nolte Lackenbach Siegel1 CHASE RD.SCARSDALE, NY 10583-4156UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Chemicals for use in the purification of proteins for in vitro use; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Kit containing pre-packed columns, chemicals, pre-made buffer concentrates, syringes and instructional manual for the purification of proteins for in vitro use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Protein in raw material form for scientific and medical research; Protein arrays and nucleotide arrays for scientific and medical research; Chemical preparations for scientific purposes; Stem cells for research or scientific purposes; Enzymes for use in protein hydrolysis; Chromatography chemicals; Electrophoresis gels; Electrophoresis gels other than for medical or veterinary purposes | ACTIVE | — |
| 009 | Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein; Scientific apparatus, namely, cellular mixed ester membranes for use in the science and research industry; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses; Laboratory chemical reactors; Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics, and contaminants; Portable detection and identification instruments using light sources and light detectors for detecting and identifying chemical and biological substances not for medical purposes; Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and computer systems for use in protein purification; Laboratory apparatus and instruments for extracting protein, not for medical purposes; Laboratory apparatus and instruments for extracting DNA, not for medical purposes; Solid phase extraction cartridges for laboratory use; Chromatography apparatus for laboratory use | ACTIVE | — |
| 035 | Pharmaceutical cost management services and drug utilization review services; Providing an online computer database for collecting and reporting controlled substance prescription drug dispensing information for business purposes; Online retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, via in-store order pickup; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies | ACTIVE | — |
| 042 | Drug evaluation, namely, pharmaceutical product evaluation; Drug research services, namely, pharmaceutical research services; drug discovery services; implementation of early evaluations in the field of new drugs; scientific investigations for medical purposes; scientific laboratory services; laboratory equipment and instrument rental; chemical analysis services; biochemical research and analysis; Chemical research and analysis; Scientific research on the mechanism of action of compound use in animals; development and testing of chemical production methods; chemical analysis; chemical synthesis evaluation services; medical research; medical laboratory services; genome structure and function analysis; stem cell research services; Blood analysis services; Biotechnology research services; medical research services; biomedical research services; Genetic screening for scientific research purposes; antibody research and development; genetic testing for scientific research purposes; development of pharmaceutical preparations and medicines; Conducting clinical trials for others; Drug testing, namely, testing of pharmaceuticals; Chemical testing; Functional testing of equipment and instruments; Information technology consulting services in the field of drug discovery; Cloud computing services featuring software for performing drug discovery processess; Computer programming for medical care | ACTIVE | — |
| 044 | Medical equipment rental; Performing diagnosis of diseases; Medication consultation; Medical consultation; Medical auxiliary services being medical services; Medical services; Chemotherapy services; Stem cell treatment services; Medical clinic services; Medical treatment of cancer; Human tissue bank services; Genetic screening for medical purposes; Genetic testing for medical purposes; Medical analysis services for cancer diagnosis; Human blood collection and preservation; Medical analysis services provided by medical laboratories for diagnosis and treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Viva Biotech (Shanghai) Limited
- Other trademarks owned by Viva Biotech (Shanghai) Limited
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VIVA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 18, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 14, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 15, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 31, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 18, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2020 | NWAP | NEW APPLICATION ENTERED | — |